EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY-NC 4.0

Selective Agonists of Thyroid Hormone Receptor Beta: Promising Tools for the Treatment of Nonalcoholic Fatty Liver Disease

Sun Wook Cho

Endocrinology and Metabolism · 30.04.2024 · 39 (2) · 285-287

DOI: 10.3803/enm.2024.203 ↗

Kurz gefasst

Editorial in der Zeitschrift Endocrinology and Metabolism, erschienen am 30.04.2024. Verfasst von Sun Wook Cho. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Thyroid Hormone Receptors beta. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thyroid hormone receptor beta (THR-β) is the primary isoform of the THR found in the liver, and it is primarily responsible for reducing cholesterol levels. Conversely, THR-α is predominant - ly associated with adverse effects on the heart and bones. Therefore, significant efforts have been made to develop drug candidates with isomer-specific activity, targeting the structure of thyroid hormones to create thyromimetics that selectively target THR-β for application in liver disease [1]

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseThyroid Hormone Receptors betaHumansAnimals

Substanzen

Thyroid Hormone Receptors beta

Autor:innen und Institutionen

  • Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

Zitieren

APA

Cho, S. W. (2024). Selective Agonists of Thyroid Hormone Receptor Beta: Promising Tools for the Treatment of Nonalcoholic Fatty Liver Disease. Endocrinology and Metabolism, 39(2), 285-287. https://doi.org/10.3803/enm.2024.203

Vancouver

Cho SW. Selective Agonists of Thyroid Hormone Receptor Beta: Promising Tools for the Treatment of Nonalcoholic Fatty Liver Disease. Endocrinology and Metabolism. 2024;39(2):285-287. doi:10.3803/enm.2024.203

BibTeX
@article{Cho2024,
  author = {Cho, Sun Wook},
  title = {Selective Agonists of Thyroid Hormone Receptor Beta: Promising Tools for the Treatment of Nonalcoholic Fatty Liver Disease},
  journal = {Endocrinology and Metabolism},
  year = {2024},
  volume = {39},
  number = {2},
  pages = {285--287},
  doi = {10.3803/enm.2024.203}
}
Kostenlos starten →